Medicine plays a vital role in safeguarding public health throughout the world. Pharmaceutical companies develop medicines to treat and cure sickness and disease. However, despite these noble intentions, occasionally substances created for a specific therapeutic purpose become dangerous. As such, federal and state governments have passed numerous laws to control and manage the prescription, use, storage, handling and disposal of such controlled substances.
To offer you and your clients deeper insights on this topic, we are pleased to announce the publication of our latest Technology whitepaper titled “DEA Controlled Substances & Regulatory Compliance” authored by Technology Risk Control Specialist Elizabeth Marazzo. In this whitepaper, she provides an overview of DEA requirements and controls that should be in place for organizations who handle, manufacture and/or store controlled substances.
Please do not hesitate to contact us with any questions. More whitepapers can be found on our website at onebeacontech.com/whitepapers.